Tunde was Senior Vice President and Chief Medical Officer at Mallinckrodt Pharmaceuticals, and Senior Vice President, Clinical Development and Medical Affairs at Boehringer Ingelheim. Tunde Otulana joined Allergy Therapeutics in 2021.
Tunde Otulana is currently
Create your alert
to follow the career of Tunde Otulana.
In 1981, Tunde Otulana completed a Doctor of Medicine at University of Ibadan.
They have also studied at University of Ibadan :
Find more alumni from University of Ibadan
Do you need to know more about Tunde Otulana? More results.
Report an error
Update the org chart details of Tunde Otulana.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.